?
Mahoney Michael F
Director
CVS Health Corporation
US, Woonsocket [HQ]
CIK
1533022
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
17,014,030,000
Price per Share :
$98.66
Equivalence :
$1,678,604,199,800.00
Transaction History
-
A17,014,030,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/06/24
-
Footnotes
-
-
Footnotes:#1 On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2023 and subject to the completion of the concurrent three-year individual service period. On February 6, 2024, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
-
F16,363,560,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/06/24
-
Footnotes
-
-
Footnotes:#1 On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2023 and subject to the completion of the concurrent three-year individual service period. On February 6, 2024, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
-
A6,201 Shares After TransactionValue : $354,077.10$125,620.00Transaction Date : 11/21/24
-
Footnotes
-
-
Footnotes:#1 Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
-
M16,528,790,000 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/14/24
-
Footnotes
-
-
Footnotes:#1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
-
F16,455,510,000 Shares After TransactionValue : $1,085,240,884,500.00$4,832,816,000.00Transaction Date : 02/14/24
-
Footnotes
-
-
Footnotes:#1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.